Advanced Cardiovascular Life Support Market Research Report - Global Forecast to 2024

Advanced Cardiovascular Life Support Market Research Report - Global Forecast to 2024

ID: MRFR/HC/0240-HCRR | December, 2017 | Region: Global | 117 pages | Half-Cooked Research Reports

Advanced Cardiovascular life support market Research Report, by application (Hospital, Clinic), by instrument (Accessories, Device), by algorithm (Tachycardia, Cardiac arrest, Bradycardia), by end-user (Doctor, Nurse, Paramedic) - Global Forecast Report 2024



About Advanced Cardiovascular life support market (ACLS):


Advanced cardiovascular life support is a set of clinical interventions for the urgent treatment of cardiac arrest, stroke and other life-threatening medical emergencies. ACLS entails airway management, accessing veins, interpretation of ECG, applications of emergency pharmacology and early defibrillation with automated external defibrillators.


Advanced Cardiovascular Life Support provides the theoretical background to resuscitation as well as explaining the essential resuscitation skills required to manage an adult cardiac arrest– from the time it occurs until subsequent transfer to the ICU.


Advanced Cardiovascular Life Support also discusses ethical and legal issues, record keeping, dealing with bereavement, audit, equipment and training– providing an essential quick reference tool for nurses and health care professionals.



Advanced cardiovascular life support market Application:


Medical personal, such as paramedics, doctors, nurses, and respiratory therapists must take a certification class to learn ACLS procedures prior to administering them. The algorithms are complex and should only be carried out by trained medical providers. Classes to become certified in ACLS are offered through hospitals, colleges, and private organizations. Managing the airway, analyzing various cardiac rhythms, and understanding what medications should be given are included in the classes.



Advanced cardiovascular life support market growth influencer:


The market growth drivers of ACLS market are: the rising prevalence of a number of cardiovascular diseases related to cerebrovascular, valvular, rheumatic, coronary artery, and peripheral vascular conditions. The raising preference for minimally invasive treatment methods, continuous up gradation and modification of products, rising population of obese and aged people across the globe, and busy modern lifestyles are also driving the advanced cardiovascular life support market.


The less availability of trained personnel is the restraint of the market.



Advanced cardiovascular life support market segmentation:


The ACLS can be segmented into algorithm, techniques, instruments, applications and end-users.


ACLS market by algorithm: Cardiac arrest, Acute Coronary Syndromes, PEA/Asystole, VF/Pulseless VT, Bradycardia, Tachycardia, and Suspected Stroke algorithms.


ACLs market by techniques: Airway management, non-invasive airway, endotracheal intubation, Electrical Therapy and Lethal Arrhythmias.


ACLs market by instruments: Device and Accessories.


ACLS market by applications: Medical Training Centers, Hospitals, Clinics And Cardiac Catheterization Labs.


ACLS market by end-users: paramedics, doctors, nurses, and respiratory therapists.



Advanced cardiovascular life support market regional analysis:


The regional analysis comprises of North America, Europe, Asia Pacific, Middle East and rest of the world.


North America:


The ACLS market is dominated by North America due to growing aging population, rising of various cardiovascular diseases, and increasing healthcare infrastructure facilities in the region, followed by Europe.


With the advancement of technology, there is an increased demand for minimally and non-invasive invasive devices, which are now being targeted by both the existing as well as new players. A number of technologies with less and minimal invasiveness are available in the market, as there is a recent trend for providing complete non-invasive solution to the patients.


Asia:


Asia is showing an emerging growth in ACLS market in upcoming years.


Cardiovascular disease is common in Asia, where it is a leading cause of death in countries from Japan to India to China. Of the 17.3 million deaths caused by cardiovascular disease each year, nearly 60 percent occur in Asia, according to the World Health Organization (WHO). These numbers are likely to rise in the near future. As Asians become wealthier, they are exercising less, consuming more “Western style”, fast food and smoking. All of these activities are risk factors for cardiovascular diseases. However, a growing focus on the prevention, treatment and diagnosis of cardiovascular disease in Asia has led to a growing demand for cardiovascular therapies and medical devices.



Advanced cardiovascular life support market major players:


Cardiac Science Corporation (U.S.), CPR Medical Devices, Inc. (Canada), General Electric Company (U.S.), Michigan Instruments (U.S.), Koninklijke Philips N.V. (Netherlands), Physio-Control, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and ZOLL Medical Corporation (Now part of Asahi Kasei Corporation (Japan)).



The reports also covers brief analysis of Geographical Region includes:


Americas

North America
o US

o Canada

o Mexico

Latin America

Europe


Western Europe
o Germany

o France

o Italy

o Spain

o U.K

o Rest of Western Europe

Eastern Europe

Asia– Pacific


Asia
o China

o India

o Japan

o Rest of Asia

Pacific Countries
o Australia

o New Zealand

· The Middle East& Africa


Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.

Table of Contents

1    Report Prologue    

2    Market Introduction    


      2.1    Introduction    

      2.2    Scope of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

5    Market Factor Analysis    

      5.1    Porter’s Five Forces Model    

            5.1.1    Bargaining power of suppliers    

            5.1.2    Bargaining Power of Buyers    

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Supply Chain Analysis    

6.    Global Advanced cardiovascular life support market by application

6.1Hospital 

      6.2 Clinic

      6.3 Diagnostic centres

      6.4 Others

7.    Global Advanced cardiovascular life support market by instrument

      7.1 Accessories

      7.2 Device

8.    Global Advanced cardiovascular life support market by end user

      8.1 Hospitals and clinics

      8.2 Home care 

      8.3 Emergency medicine 

      8.5 Others

9.    Global Advanced cardiovascular life support market by region

      9.1    Introduction

      9.1    Introduction

      9.2    North America

                9.2.1.1     US

                9.2.1.2     Canada

            9.2.2 South America

      9.3     Europe

      9.3.1Germany

            9.3.2 France

            9.3.3 Italy

            9.3.4 Spain

            9.3.5 UK

            9.3.6 Rest of Europe

      9.4    Asia Pacific

            9.4.1    China

            9.4.2    India

            9.4.3    Japan

            9.4.4   Republic of Korea

            9.4.5    Australia

            9.4.6    Rest of Asia

      9.5    Middle East and Africa

            9.5.1     United Arab Emirates

            9.5.2    Saudi Arabia

            9.5.4    Rest of Middle East and Africa

10    Competitive Landscape    

      10.1    Cost of treatment    

      10.2    Production Capacity of Major Players    

11    Company Profile    

      11.1    Cardiac Science Corporation

            11.1.1    Overview    

            11.1.2    Product/Business Segment Overview    

            11.1.3    Financial Updates    

            11.1.4    Key Developments    

      11.2    CPR Medical Devices Inc.

            11.2.1    Overview    

            11.2.2    Product/Business Segment Overview    

            11.2.3    Financial Updates    

            11.2.4    Key Developments    

      11.3    General Electric Company

            11.3.1    Overview    

            11.3.2    Product/Business Segment Overview    

            11.3.3    Financial Updates    

      11.4    Michigan Instruments    

            11.4.1    Overview    

            11.4.2    Product/Business Segment Overview    

            11.4.3    Financial Updates

            11.4.4    Key Development

      11.5    Koninklijke Philips N.V.     

            11.5.1    Overview    

            11.5.2    Product/Business Segment Overview    

            11.5.3    Financial Updates    

            11.5.4    Key Developments    

      11.6    Physio-Control Inc.

            11.6.1    Overview    

            11.6.2    Product/Business Segment Overview    

            11.6.3    Financial Updates    

            11.6.4    Key Developments

      11.7    St. Jude Medical Inc. 

            11.7.1    Overview    

            11.7.2    Product/Business Segment Overview    

            11.7.3    Financial Updates    

            11.7.4    Key Developments    

      11.8    ZOLL Medical Corporation 

            11.8.1    Overview    

            11.8.2    Product/Business Segment Overview    

            11.8.3    Financial Updates    

            11.8.4    Key Developments        

      11.9    Others

12       Conclusion

      12.1       Key Findings

            12.1.1    From CEO’s Viewpoint 

            12.1.2    Unmet Needs of the Market 

      12.2       Key Companies to Watch

      12.3       Prediction of ventilation device Industry

13    Appendix